Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Migration through a small pore disrupts inactive chromatin organization in neutrophil-like cells.

Jacobson EC, Perry JK, Long DS, Olins AL, Olins DE, Wright BE, Vickers MH, O'Sullivan JM.

BMC Biol. 2018 Nov 26;16(1):142. doi: 10.1186/s12915-018-0608-2.

2.

The genetic architecture of type 1 diabetes mellitus.

Nyaga DM, Vickers MH, Jefferies C, Perry JK, O'Sullivan JM.

Mol Cell Endocrinol. 2018 Dec 5;477:70-80. doi: 10.1016/j.mce.2018.06.002. Epub 2018 Jun 18. Review.

PMID:
29913182
3.

Human Placental Growth Hormone Variant in Pathological Pregnancies.

Liao S, Vickers MH, Stanley JL, Baker PN, Perry JK.

Endocrinology. 2018 May 1;159(5):2186-2198. doi: 10.1210/en.2018-00037.

PMID:
29659791
4.

Maternal serum placental growth hormone, insulin-like growth factors and their binding proteins at 20 weeks' gestation in pregnancies complicated by gestational diabetes mellitus.

Liao S, Vickers MH, Taylor RS, Fraser M, McCowan LME, Baker PN, Perry JK.

Hormones (Athens). 2017 Jul;16(3):282-290. doi: 10.14310/horm.2002.1747.

5.

Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).

Koltun DO, Parkhill EQ, Kalla R, Perry TD, Elzein E, Li X, Simonovich SP, Ziebenhaus C, Hansen TR, Marchand B, Hung WK, Lagpacan L, Hung M, Aoyama RG, Murray BP, Perry JK, Somoza JR, VillaseƱor AG, Pagratis N, Zablocki JA.

Bioorg Med Chem Lett. 2017 Oct 20. pii: S0960-894X(17)31034-X. doi: 10.1016/j.bmcl.2017.10.040. [Epub ahead of print]

PMID:
29254643
6.

The GDNF Family: A Role in Cancer?

Fielder GC, Yang TW, Razdan M, Li Y, Lu J, Perry JK, Lobie PE, Liu DX.

Neoplasia. 2018 Jan;20(1):99-117. doi: 10.1016/j.neo.2017.10.010. Epub 2017 Dec 12. Review.

7.

Maternal serum IGF-1, IGFBP-1 and 3, and placental growth hormone at 20weeks' gestation in pregnancies complicated by preeclampsia.

Liao S, Vickers MH, Taylor RS, Jones B, Fraser M, McCowan LME, Baker PN, Perry JK.

Pregnancy Hypertens. 2017 Oct;10:149-154. doi: 10.1016/j.preghy.2017.07.148. Epub 2017 Jul 27.

PMID:
29153669
8.

Genome organization: connecting the developmental origins of disease and genetic variation.

Jacobson E, Vickers MH, Perry JK, O'Sullivan JM.

J Dev Orig Health Dis. 2018 Jun;9(3):260-265. doi: 10.1017/S2040174417000678. Epub 2017 Aug 29.

PMID:
28847340
9.

Manipulation of the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) Axis: A Treatment Strategy to Reverse the Effects of Early Life Developmental Programming.

Reynolds CM, Perry JK, Vickers MH.

Int J Mol Sci. 2017 Aug 8;18(8). pii: E1729. doi: 10.3390/ijms18081729. Review.

10.

Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology.

Perry JK, Wu ZS, Mertani HC, Zhu T, Lobie PE.

Trends Endocrinol Metab. 2017 Aug;28(8):587-596. doi: 10.1016/j.tem.2017.05.003. Epub 2017 Jun 13. Review.

PMID:
28622965
11.

Human placental growth hormone is increased in maternal serum at 20 weeks of gestation in pregnancies with large-for-gestational-age babies.

Liao S, Vickers MH, Taylor RS, Jones B, Fraser M, McCowan LM, Baker PN, Perry JK.

Growth Factors. 2016 Dec;34(5-6):203-209. doi: 10.1080/08977194.2016.1273223. Epub 2017 Jan 25.

PMID:
28122472
12.

A potential role for genome structure in the translation of mechanical force during immune cell development.

Jacobson E, Perry JK, Long DS, Vickers MH, O'Sullivan JM.

Nucleus. 2016 Sep 2;7(5):462-475. Epub 2016 Sep 27. Review.

13.

Comparison of pulsatile vs. continuous administration of human placental growth hormone in female C57BL/6J mice.

Liao S, Vickers MH, Evans A, Stanley JL, Baker PN, Perry JK.

Endocrine. 2016 Oct;54(1):169-181. Epub 2016 Aug 11.

PMID:
27515803
14.

WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells.

Vouyovitch CM, Perry JK, Liu DX, Bezin L, Vilain E, Diaz JJ, Lobie PE, Mertani HC.

Endocr Relat Cancer. 2016 Jul;23(7):571-85. doi: 10.1530/ERC-15-0528. Epub 2016 Jun 20.

PMID:
27323961
15.

Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model.

Evans A, Jamieson SM, Liu DX, Wilson WR, Perry JK.

Cancer Lett. 2016 Aug 28;379(1):117-23. doi: 10.1016/j.canlet.2016.05.031. Epub 2016 May 27.

PMID:
27241667
16.

Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma.

Kong X, Wu W, Yuan Y, Pandey V, Wu Z, Lu X, Zhang W, Chen Y, Wu M, Zhang M, Li G, Tan S, Qian P, Perry JK, Lobie PE, Zhu T.

Oncotarget. 2016 May 17;7(20):29465-79. doi: 10.18632/oncotarget.8781.

17.

Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Castro I, Giret TM, Magnani DM, Maxwell HS, Umland O, Perry JK, Pecotte JK, Brasky KM, Barber GN, Desrosiers RC, Watkins DI.

J Virol. 2016 May 12;90(11):5280-5291. doi: 10.1128/JVI.00281-16. Print 2016 Jun 1.

18.

The Placental Variant of Human Growth Hormone Reduces Maternal Insulin Sensitivity in a Dose-Dependent Manner in C57BL/6J Mice.

Liao S, Vickers MH, Stanley JL, Ponnampalam AP, Baker PN, Perry JK.

Endocrinology. 2016 Mar;157(3):1175-86. doi: 10.1210/en.2015-1718. Epub 2015 Dec 15.

PMID:
26671184
19.

Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.

Feng JY, Xu Y, Barauskas O, Perry JK, Ahmadyar S, Stepan G, Yu H, Babusis D, Park Y, McCutcheon K, Perron M, Schultz BE, Sakowicz R, Ray AS.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):806-17. doi: 10.1128/AAC.01922-15. Print 2016 Feb.

20.

Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, Kong X, Tan S, Ding K, Perry JK, Wu Z, Cao Y, Lobie PE, Zhu T.

J Biol Chem. 2015 May 29;290(22):13812-29. doi: 10.1074/jbc.M115.653261. Epub 2015 Apr 14.

21.

Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation.

Perera O, Evans A, Pertziger M, MacDonald C, Chen H, Liu DX, Lobie PE, Perry JK.

Cancer Lett. 2015 May 28;361(1):104-11. doi: 10.1016/j.canlet.2015.02.051. Epub 2015 Mar 3.

PMID:
25748388
22.

Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase.

Appleby TC, Perry JK, Murakami E, Barauskas O, Feng J, Cho A, Fox D 3rd, Wetmore DR, McGrath ME, Ray AS, Sofia MJ, Swaminathan S, Edwards TE.

Science. 2015 Feb 13;347(6223):771-5. doi: 10.1126/science.1259210.

23.

An international ecological study of adult height in relation to cancer incidence for 24 anatomical sites.

Jiang Y, Marshall RJ, Walpole SC, Prieto-Merino D, Liu DX, Perry JK.

Cancer Causes Control. 2015 Mar;26(3):493-9. doi: 10.1007/s10552-014-0520-1. Epub 2015 Jan 10.

PMID:
25575587
24.

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.

Jung Y, Abdel-Fatah TM, Chan SY, Nolan CC, Green AR, Ellis IO, Li L, Huang B, Lu J, Xu B, Chen L, Ma RZ, Zhang M, Wang J, Wu Z, Zhu T, Perry JK, Lobie PE, Liu DX.

Cancer Res. 2013 Dec 1;73(23):6951-62. doi: 10.1158/0008-5472.CAN-13-0982.

25.

X-linked microtubule-associated protein, Mid1, regulates axon development.

Lu T, Chen R, Cox TC, Moldrich RX, Kurniawan N, Tan G, Perry JK, Ashworth A, Bartlett PF, Xu L, Zhang J, Lu B, Wu M, Shen Q, Liu Y, Richards LJ, Xiong Z.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19131-6. doi: 10.1073/pnas.1303687110. Epub 2013 Nov 5.

26.

Growth hormone and cancer: an update on progress.

Perry JK, Liu DX, Wu ZS, Zhu T, Lobie PE.

Curr Opin Endocrinol Diabetes Obes. 2013 Aug;20(4):307-13. doi: 10.1097/MED.0b013e328363183a. Review.

PMID:
23807602
27.

Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis.

Bougen NM, Amiry N, Yuan Y, Kong XJ, Pandey V, Vidal LJ, Perry JK, Zhu T, Lobie PE.

Cancer Lett. 2013 May 10;332(1):19-29. doi: 10.1016/j.canlet.2012.12.012. Epub 2012 Dec 22.

PMID:
23266572
28.

The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.

Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.

Int J Oncol. 2012 Dec;41(6):2285-95. doi: 10.3892/ijo.2012.1660. Epub 2012 Oct 15.

PMID:
23064471
29.

Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.

Bougen NM, Steiner M, Pertziger M, Banerjee A, Brunet-Dunand SE, Zhu T, Lobie PE, Perry JK.

Endocr Relat Cancer. 2012 Sep 14;19(5):625-44. doi: 10.1530/ERC-12-0042. Print 2012 Oct.

PMID:
22807498
30.

Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

Wu ZS, Yang K, Wan Y, Qian PX, Perry JK, Chiesa J, Mertani HC, Zhu T, Lobie PE.

J Clin Endocrinol Metab. 2011 Oct;96(10):E1619-29. doi: 10.1210/jc.2011-1245. Epub 2011 Aug 17.

PMID:
21849525
31.

Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.

Bougen NM, Yang T, Chen H, Lobie PE, Perry JK.

Oncol Rep. 2011 Aug;26(2):487-93. doi: 10.3892/or.2011.1305. Epub 2011 May 11.

PMID:
21567106
32.

Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors.

Lansdon EB, Liu Q, Leavitt SA, Balakrishnan M, Perry JK, Lancaster-Moyer C, Kutty N, Liu X, Squires NH, Watkins WJ, Kirschberg TA.

Antimicrob Agents Chemother. 2011 Jun;55(6):2905-15. doi: 10.1128/AAC.01594-10. Epub 2011 Apr 4.

33.

Optimized high-throughput screen for hepatitis C virus translation inhibitors.

Berry KE, Peng B, Koditek D, Beeman D, Pagratis N, Perry JK, Parrish J, Zhong W, Doudna JA, Shih IH.

J Biomol Screen. 2011 Feb;16(2):211-20. doi: 10.1177/1087057110391665.

34.

Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.

Kannan N, Kang J, Kong X, Tang J, Perry JK, Mohankumar KM, Miller LD, Liu ET, Mertani HC, Zhu T, Grandison PM, Liu DX, Lobie PE.

Neoplasia. 2010 Dec;12(12):1041-53.

35.

STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone.

Tang JZ, Kong XJ, Banerjee A, Muniraj N, Pandey V, Steiner M, Perry JK, Zhu T, Liu DX, Lobie PE.

Endocrinology. 2010 Sep;151(9):4133-45. doi: 10.1210/en.2010-0273. Epub 2010 Jul 28.

PMID:
20668024
36.

Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2.

Tang JZ, Kong XJ, Kang J, Fielder GC, Steiner M, Perry JK, Wu ZS, Yin Z, Zhu T, Liu DX, Lobie PE.

Mol Cancer Ther. 2010 Jun;9(6):1697-708. doi: 10.1158/1535-7163.MCT-09-1077. Epub 2010 Jun 8.

37.

Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.

Kang J, Qian PX, Pandey V, Perry JK, Miller LD, Liu ET, Zhu T, Liu DX, Lobie PE.

Oncogene. 2010 Jun 3;29(22):3228-40. doi: 10.1038/onc.2010.71. Epub 2010 Mar 22. Erratum in: Oncogene. 2012 Jan 19;31(3):402.

PMID:
20305694
38.

PAX5alpha enhances the epithelial behavior of human mammary carcinoma cells.

Vidal LJ, Perry JK, Vouyovitch CM, Pandey V, Brunet-Dunand SE, Mertani HC, Liu DX, Lobie PE.

Mol Cancer Res. 2010 Mar;8(3):444-56. doi: 10.1158/1541-7786.MCR-09-0368. Epub 2010 Mar 2.

39.

Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.

Pandey V, Qian PX, Kang J, Perry JK, Mitchell MD, Yin Z, Wu ZS, Liu DX, Zhu T, Lobie PE.

Endocrinology. 2010 Mar;151(3):909-20. doi: 10.1210/en.2009-0979. Epub 2010 Jan 29. Erratum in: Endocrinology. 2012 Jan;153(1):540.

PMID:
20118197
40.

Regulation of invasive growth: similar epigenetic mechanisms underpin tumour progression and implantation in human pregnancy.

Perry JK, Lins RJ, Lobie PE, Mitchell MD.

Clin Sci (Lond). 2009 Dec 23;118(7):451-7. doi: 10.1042/CS20090503.

PMID:
20025611
41.

Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.

Tang JZ, Zuo ZH, Kong XJ, Steiner M, Yin Z, Perry JK, Zhu T, Liu DX, Lobie PE.

Endocrinology. 2010 Jan;151(1):43-55. doi: 10.1210/en.2009-0651. Epub 2009 Dec 4.

PMID:
19966185
42.

Signal Transducer and Activator of Transcription (STAT)-A and STAT5B Differentially Regulate Human Mammary Carcinoma Cell Behavior.

Tang JZ, Zuo ZH, Kong XJ, Steiner M, Yin Z, Perry JK, Zhu T, Liu DX, Lobie PE.

Endocr Rev. 2009 Dec 1;30(7):929. doi: 10.1210/edrv.30.7.9992. No abstract available.

PMID:
28199519
43.

RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.

Kirschberg TA, Balakrishnan M, Squires NH, Barnes T, Brendza KM, Chen X, Eisenberg EJ, Jin W, Kutty N, Leavitt S, Liclican A, Liu Q, Liu X, Mak J, Perry JK, Wang M, Watkins WJ, Lansdon EB.

J Med Chem. 2009 Oct 8;52(19):5781-4. doi: 10.1021/jm900597q.

PMID:
19791799
44.

Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells.

Amiry N, Kong X, Muniraj N, Kannan N, Grandison PM, Lin J, Yang Y, Vouyovitch CM, Borges S, Perry JK, Mertani HC, Zhu T, Liu D, Lobie PE.

Endocrinology. 2009 Oct;150(10):4473-83. doi: 10.1210/en.2009-0066. Epub 2009 Jul 9.

PMID:
19589871
45.

Artemin is oncogenic for human mammary carcinoma cells.

Kang J, Perry JK, Pandey V, Fielder GC, Mei B, Qian PX, Wu ZS, Zhu T, Liu DX, Lobie PE.

Oncogene. 2009 May 14;28(19):2034-45. doi: 10.1038/onc.2009.66. Epub 2009 Apr 13.

PMID:
19363524
46.

Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.

Brunet-Dunand SE, Vouyovitch C, Araneda S, Pandey V, Vidal LJ, Print C, Mertani HC, Lobie PE, Perry JK.

Endocrinology. 2009 Mar;150(3):1341-52. doi: 10.1210/en.2008-0608. Epub 2008 Oct 30.

PMID:
18974274
47.

Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Pandey V, Perry JK, Mohankumar KM, Kong XJ, Liu SM, Wu ZS, Mitchell MD, Zhu T, Lobie PE.

Endocrinology. 2008 Aug;149(8):3909-19. doi: 10.1210/en.2008-0286. Epub 2008 May 1.

48.

Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.

Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, Emerald BS, Lobie PE.

Endocrinology. 2008 May;149(5):2219-29. doi: 10.1210/en.2007-1320. Epub 2008 Feb 14.

PMID:
18276758
49.

The contribution of growth hormone to mammary neoplasia.

Perry JK, Mohankumar KM, Emerald BS, Mertani HC, Lobie PE.

J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):131-45. doi: 10.1007/s10911-008-9070-z. Epub 2008 Feb 7. Review.

50.

Are trefoil factors oncogenic?

Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE.

Trends Endocrinol Metab. 2008 Mar;19(2):74-81. Epub 2007 Dec 3. Review.

PMID:
18054496

Supplemental Content

Loading ...
Support Center